Sanofi, 10% Owner at REGENERON PHARMACEUTICALS, INC. (REGN), sold 345,808 shares at $281.15 ($97.2M) on 2019-09-10, disclosed to the SEC on 2019-09-12.
Open-market sale of $97.2M REGN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $281.15 | 172,904 | $48.6M | 50.0% |
| 2 | $281.15 | 172,904 | $48.6M | 50.0% |
| Total | $281.15 avg | 345,808 | $97.2M | 100% |
| Filing → |
| ICVX | BUY | 2021-08-02 | $1.0M | — | Filing → |
| INZY | BUY | 2020-07-29 | $1.3M | — | Filing → |
| REGN | SELL | 2020-06-11 | $143.7M | — | Filing → |